Skip to content

Performance Study of the Thermodiag Solution for Body Temperature Measurement

Evaluation of PERThermodiag® Medical Device for CT Temperature Measurement and Anomaly Detection Compared to Reference Methods in Critical Care Hospitalized Patients: a Comparative, Multi-center Interventional Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06703931
Acronym
ThermodiagPERF
Enrollment
60
Registered
2024-11-25
Start date
2024-11-26
Completion date
2025-03-30
Last updated
2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Department Visit, Temperature Change, Body

Keywords

Temperature, Body temperature, Monitoring temperature, multisensors, Actimetry, Actigraphy, Heart rate, Continuous measurement, Contextualized measure, Dedicated machine learning model, Machine Learning

Brief summary

The goal of this prospective, comparative, multi-centre interventional clinical investigation, is to evaluate the performance of the Thermodiag® medical device, compared with reference methods, for continuous measurement of core temperature in critical care patients. The main question it aims to answer is to develop non-invasive alternatives to the current methods of measuring core body, to reduce health risks, and overcome various other limitations (as infection, bleeding, thrombosis and local reactions).

Interventions

In intensive care Medics will use a reference medical device and Thermodiag®. Simultaneous and synchronised measurements will be taken every minute.

Sponsors

Clinact Multihealth
CollaboratorUNKNOWN
Digital Medical Hub
CollaboratorOTHER
F2D Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Masking description

Sponsor

Intervention model description

Prospective, comparative, multi-centre interventional clinical investigation

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 to 80 years; * Female or male patients; * Patients hospitalised in a critical care unit as defined by the Public Health Code of the Republic of France, Article R6123-33: 'The critical care activity consists of the care of patients who present or are likely to present one or more acute failures directly threatening the vital or functional prognosis and which may require recourse to one or more methods of substitution'. * Patients affiliated to the social security system or beneficiaries of such a system, where applicable, in accordance with local regulations; * Voluntary patients - or trusted person/family member/relative who have given oral and written consent after being informed by the investigator of the research.

Exclusion criteria

* Patients with a corpulence or physical characteristics responsible for a 'tourniquet' effect: arm circumference greater than 47 centimetres; * Patients with burns on the arm (location for Thermodiag® measurement); * Patients with particularly sensitive or affected skin in the biceps or armpit (left and right); * Patients undergoing an MRI examination; * Patients undergoing extracorporeal circulation; * Patients with a history of allergy to silicone; * Patients with active implantable medical devices such as pacemakers, defibrillators, etc. ; * Patients undergoing dialysis; * Patients with a tattoo in the area where the investigational device will be worn (arm); * Patients currently excluded from another protocol or taking part in another interventional research study; * Pregnant or breast-feeding women.

Design outcomes

Primary

MeasureTime frameDescription
Body temperature MeasurementEvery minute from the enrollment to the end of medical treatment (estimated time : 8 days)The degree of agreement between the two medical devices (Thermodiag® versus reference method in the hospital unit) will be assessed (expected measure is less than 0.1°C).

Countries

France

Contacts

Primary ContactBenjamin MENARD, PhD
b.menard@f2d-medical.fr+33658918607

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026